Qube Research & Technologies Ltd - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,431,090
-49.7%
45,259
-35.1%
0.00%
-60.0%
Q2 2023$2,843,997
+232.3%
69,740
+203.7%
0.01%
+150.0%
Q1 2023$855,943
-1.2%
22,966
-7.5%
0.00%
-20.0%
Q4 2022$866,493
-28.0%
24,835
+49.9%
0.01%
-50.0%
Q1 2022$1,204,000
+442.3%
16,572
+903.1%
0.01%
+233.3%
Q3 2021$222,000
-92.6%
1,652
-91.1%
0.00%
-91.2%
Q2 2021$3,009,00018,5840.03%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders